Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder that affects the cilia, the tiny hair-like structures that line the airways, ears, and other parts of the body. The CFAP298 gene has been identified as one of the genetic contributors to PCD, specifically known as Primary Ciliary Dyskinesia Type 26. Understanding the symptoms associated with this condition is crucial for early diagnosis and management. DNA Labs UAE offers a genetic test for this specific gene mutation, aiding in the identification and understanding of this condition.
Understanding Primary Ciliary Dyskinesia Type 26
Primary Ciliary Dyskinesia Type 26, associated with mutations in the CFAP298 gene, is characterized by chronic respiratory tract infections, reduced fertility, and other symptoms related to defective ciliary function. The cilia play a vital role in the body, moving mucus and other substances through the airways, reproductive system, and other parts of the body. When they are not working correctly due to a genetic mutation like in CFAP298, it can lead to a range of health issues.
Symptoms of CFAP298 Gene Primary Ciliary Dyskinesia Type 26
The symptoms of CFAP298 Gene Primary Ciliary Dyskinesia Type 26 can vary widely among individuals but commonly include:
- Chronic cough and respiratory infections from an early age
- Recurrent ear infections, which may lead to hearing loss
- Sinusitis and nasal congestion
- Situs inversus or the mirror image reversal of internal organs in about 50% of cases
- Infertility issues due to impaired motility of sperm or dysfunctional fallopian tube cilia
Early diagnosis and management of these symptoms are crucial in improving the quality of life for individuals with PCD Type 26.
Genetic Testing for CFAP298 Gene Primary Ciliary Dyskinesia Type 26
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the CFAP298 gene, which can confirm a diagnosis of Primary Ciliary Dyskinesia Type 26. This test is an important step for individuals experiencing symptoms consistent with PCD or for those with a family history of the condition. Genetic testing can provide definitive answers and guide treatment and management strategies.
Cost of the Genetic Test
The cost of the CFAP298 Gene Primary Ciliary Dyskinesia Type 26 genetic test at DNA Labs UAE is 4400 AED. While the cost may seem significant, the information gained from this test can be invaluable in managing the condition effectively and improving the overall quality of life for those affected.
Conclusion
Primary Ciliary Dyskinesia Type 26 is a challenging condition, but with early diagnosis and appropriate management, individuals can lead full and active lives. The genetic test offered by DNA Labs UAE for the CFAP298 gene mutation is a crucial tool in the diagnosis and understanding of this condition. For more information and to arrange for testing, visit DNA Labs UAE.
